Treatment of Odontogenic Maxillary Sinusitis with the Use of Growth Factors in Advanced Platelet-Rich Fibrin for Immediate Closure of Oro-Antral Communication: A Case Report

Int J Mol Sci. 2024 Apr 14;25(8):4339. doi: 10.3390/ijms25084339.

Abstract

Chronic odontogenic maxillary sinusitis (COMS), a prolonged inflammation of the maxillary sinus lasting over 12 weeks, is often a result of periapical lesions, marginal periodontitis, and complications like oro-antral communication (OAC) and fistula (OAF). OAC, commonly emerging post-teeth extraction in the lateral maxilla, lacks documented treatments using advanced platelet-rich fibrin (A-PRF). This study evaluates A-PRF's efficacy in treating COMS and immediately sealing extensive OAC. A case of a 28-year-old male with COMS linked to a periapical lesion and supernumerary molars is presented. Treatment involved extracting specific teeth while preserving adjacent ones and using A-PRF for immediate OAC closure. A-PRF, enriched with growth factors, was pivotal in healing, showcasing enhanced tissue regeneration, pain reduction, and faster recovery. The findings suggest A-PRF as an effective adjunct in treating extensive OAC and COMS, proposing its inclusion in standard treatment protocols. This study underscores A-PRF's potential in improving outcomes for patients with COMS and related complications.

Keywords: autografts; bone regeneration; growth factor; maxillary sinusitis; oro-antral fistula; plasma; platelet-rich fibrin.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Humans
  • Intercellular Signaling Peptides and Proteins / therapeutic use
  • Male
  • Maxillary Sinus / surgery
  • Maxillary Sinusitis* / drug therapy
  • Oroantral Fistula / surgery
  • Platelet-Rich Fibrin* / metabolism
  • Tooth Extraction

Substances

  • Intercellular Signaling Peptides and Proteins

Grants and funding

This research received no external funding.